Ensign Peak Advisors, Inc Exact Sciences Corp Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 1,201,475 shares of EXAS stock, worth $59.5 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,201,475

Previous 1,815,137 33.81%

Holding current value

$59.5 Million

Previous $76.7 Million 6.68%

% of portfolio

0.15%

Previous 0.14%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$42.43 - $70.83 $26 Million - $43.5 Million	-613,662 Reduced 33.81%	1,201,475 $81.8 Million
Q2 2024 Aug 13, 2024	SELL	$41.33 - $74.26 $25,087 - $45,075	-607 Reduced 0.03%	1,815,137 $76.7 Million
Q1 2024 May 14, 2024	BUY	$56.27 - $73.77 $16.4 Million - $21.5 Million	290,841 Added 19.07%	1,815,744 $125 Million
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $29.5 Million - $37.8 Million	-498,679 Reduced 24.64%	1,524,903 $113 Million
Q3 2023 Nov 13, 2023	SELL	$65.94 - $99.04 $34.6 Million - $52 Million	-524,645 Reduced 20.59%	2,023,582 $138 Million
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $19.3 Million - $29.3 Million	-308,179 Reduced 10.79%	2,548,227 $239 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $12 Million - $18 Million	254,519 Added 9.78%	2,856,406 $194 Million
Q4 2022 Feb 13, 2023	BUY	$30.35 - $53.15 $30 Million - $52.6 Million	988,811 Added 61.3%	2,601,887 $129 Million
Q3 2022 Nov 14, 2022	SELL	$31.97 - $49.37 $17 Million - $26.2 Million	-530,300 Reduced 24.74%	1,613,076 $52.4 Million
Q2 2022 Aug 12, 2022	SELL	$35.61 - $76.23 $3.51 Million - $7.52 Million	-98,672 Reduced 4.4%	2,143,376 $84.4 Million
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $8.45 Million - $12.1 Million	-146,764 Reduced 6.14%	2,242,048 $157 Million
Q4 2021 Feb 11, 2022	BUY	$72.5 - $100.68 $29.5 Million - $40.9 Million	406,554 Added 20.51%	2,388,812 $186 Million
Q3 2021 Nov 12, 2021	BUY	$90.24 - $124.05 $10.8 Million - $14.8 Million	119,426 Added 6.41%	1,982,258 $189 Million
Q2 2021 Aug 13, 2021	BUY	$93.66 - $139.27 $9.66 Million - $14.4 Million	103,177 Added 5.86%	1,862,832 $232 Million
Q1 2021 May 12, 2021	BUY	$116.57 - $155.01 $3.09 Million - $4.1 Million	26,468 Added 1.53%	1,759,655 $232 Million
Q4 2020 Feb 12, 2021	SELL	$99.61 - $142.12 $34 Million - $48.6 Million	-341,750 Reduced 16.47%	1,733,187 $230 Million
Q3 2020 Nov 12, 2020	SELL	$72.92 - $102.01 $14.7 Million - $20.6 Million	-201,707 Reduced 8.86%	2,074,937 $212 Million
Q2 2020 Aug 12, 2020	SELL	$55.75 - $92.75 $43 Million - $71.5 Million	-771,335 Reduced 25.31%	2,276,644 $198 Million
Q1 2020 May 11, 2020	BUY	$37.9 - $104.44 $30.3 Million - $83.6 Million	800,317 Added 35.61%	3,047,979 $177 Million
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $175 Million - $224 Million	2,247,662 New	2,247,662 $208 Million

Others Institutions Holding EXAS

# of Institutions

671

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.77B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Exact Sciences Corp Transaction History